{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T15:51:34Z","timestamp":1789919494028,"version":"4.0.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.brainres.2007.08.033","type":"journal-article","created":{"date-parts":[[2007,8,24]],"date-time":"2007-08-24T08:05:20Z","timestamp":1187942720000},"page":"132-140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Complement 3-deficient mice are not protected against MPTP-induced dopaminergic neurotoxicity"],"prefix":"10.1016","volume":"1178","author":[{"given":"Yajie","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shurong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanliang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingyin","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2007.08.033_bib1","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/ar.1090940210","article-title":"Estimation of nuclear population from microtome sections","volume":"94","author":"Abercrombie","year":"1946","journal-title":"Anat. Rec."},{"key":"10.1016\/j.brainres.2007.08.033_bib2","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/glia.10069","article-title":"Expression of the complement C3a and C5a receptors after permanent focal ischemia: an alternative interpretation","volume":"38","author":"Barnum","year":"2002","journal-title":"Glia"},{"key":"10.1016\/j.brainres.2007.08.033_bib3","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/1098-2396(20001201)38:3<363::AID-SYN16>3.0.CO;2-A","article-title":"Spontaneous long-term compensatory dopaminergic sprouting in MPTP-treated mice","volume":"38","author":"Bezard","year":"2000","journal-title":"Synapse"},{"key":"10.1016\/j.brainres.2007.08.033_bib4","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.neulet.2005.07.015","article-title":"C3a expressed in the central nervous system protects against LPS-induced shock","volume":"387","author":"Boos","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2007.08.033_bib5","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson's disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.brainres.2007.08.033_bib6","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/0006-8993(94)91541-5","article-title":"Parkinsonian serum carries complement-dependent toxicity for rat mesencephalic dopaminergic neurons in culture","volume":"633","author":"Defazio","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2007.08.033_bib7","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.imlet.2003.11.019","article-title":"Regulation of mast cell activation by complement-derived peptides","volume":"92","author":"Erdei","year":"2004","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.brainres.2007.08.033_bib8","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Franklin","year":"2001"},{"key":"10.1016\/j.brainres.2007.08.033_bib9","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1523\/JNEUROSCI.3309-03.2004","article-title":"Caspase-11 mediates inflammatory dopaminergic cell death in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease","volume":"24","author":"Furuya","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2007.08.033_bib10","doi-asserted-by":"crossref","first-page":"6181","DOI":"10.1523\/JNEUROSCI.23-15-06181.2003","article-title":"Critical role for microglial NADPH oxidase in rotenone-induced degeneration of dopaminergic neurons","volume":"23","author":"Gao","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2007.08.033_bib11","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1096\/fj.03-0109fje","article-title":"Critical role of microglial NADPH oxidase-derived free radicals in the in vitro MPTP model of Parkinson's disease","volume":"17","author":"Gao","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.brainres.2007.08.033_bib12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0162-3109(00)80302-1","article-title":"Complement components of the innate immune system in health and disease in the CNS","volume":"49","author":"Gasque","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.brainres.2007.08.033_bib13","doi-asserted-by":"crossref","first-page":"5614","DOI":"10.1523\/JNEUROSCI.18-15-05614.1998","article-title":"Induction of interleukin-1 associated with compensatory dopaminergic sprouting in the denervated striatum of young mice: model of aging and neurodegenerative disease","volume":"18","author":"Ho","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2007.08.033_bib14","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nm1419","article-title":"Generation of C5a in the absence of C3: a new complement activation pathway","volume":"12","author":"Huber-Lang","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.brainres.2007.08.033_bib15","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1742-2094-3-8","article-title":"Interleukin-1beta and anaphylatoxins exert a synergistic effect on NGF expression by astrocytes","volume":"3","author":"Jauneau","year":"2006","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.brainres.2007.08.033_bib16","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.4049\/jimmunol.170.5.2331","article-title":"Expression of complement 3 and complement 5 in newt limb and lens regeneration","volume":"170","author":"Kimura","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.brainres.2007.08.033_bib17","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.bbrc.2007.04.055","article-title":"Complement activation by islet amyloid polypeptide (IAPP) and alpha-synuclein 112","volume":"357","author":"Klegeris","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.brainres.2007.08.033_bib18","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.pbb.2004.03.006","article-title":"Biochemical, behavioral and immunohistochemical alterations in MPTP-treated mouse model of Parkinson's disease","volume":"78","author":"Kurosaki","year":"2004","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.brainres.2007.08.033_bib19","doi-asserted-by":"crossref","first-page":"8447","DOI":"10.1523\/JNEUROSCI.21-21-08447.2001","article-title":"Microglial activation and dopaminergic cell injury: an in vitro model relevant to Parkinson's disease","volume":"21","author":"Le","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2007.08.033_bib20","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.neulet.2006.02.061","article-title":"Potential neuroprotective effect of low dose whole-body gamma-irradiation against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic toxicity in C57 mice","volume":"400","author":"Liang","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2007.08.033_bib21","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/70978","article-title":"Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease","volume":"5","author":"Liberatore","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.brainres.2007.08.033_bib22","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1124\/jpet.102.043166","article-title":"Dextromethorphan protects dopaminergic neurons against inflammation-mediated degeneration through inhibition of microglial activation","volume":"305","author":"Liu","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainres.2007.08.033_bib23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1742-2094-3-29","article-title":"Complement activation in the Parkinson's disease substantia nigra: an immunocytochemical study","volume":"3","author":"Loeffler","year":"2006","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.brainres.2007.08.033_bib24","doi-asserted-by":"crossref","first-page":"747","DOI":"10.4049\/jimmunol.173.2.747","article-title":"C3a and C3b activation products of the third component of complement (C3) are critical for normal liver recovery after toxic injury","volume":"173","author":"Markiewski","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.brainres.2007.08.033_bib25","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S1471-4906(02)02287-1","article-title":"Complement: more than a \u2018guard\u2019 against invading pathogens?","volume":"23","author":"Mastellos","year":"2002","journal-title":"Trends Immunol."},{"issue":"Suppl 1","key":"10.1016\/j.brainres.2007.08.033_bib26","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.parkreldis.2004.01.005","article-title":"Inflammation and neurodegeneration in Parkinson's disease","volume":"10","author":"Mcgeer","year":"2004","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.brainres.2007.08.033_bib27","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1006\/bbrc.1998.8986","article-title":"Spontaneous regeneration of nigrostriatal dopaminergic neurons in MPTP-treated C57BL\/6 mice","volume":"248","author":"Mitsumoto","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.brainres.2007.08.033_bib28","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1523\/JNEUROSCI.17-02-00615.1997","article-title":"Mechanisms of C5a and C3a complement fragment-induced [Ca2+]i signaling in mouse microglia","volume":"17","author":"Moller","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2007.08.033_bib29","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1046\/j.1471-4159.2001.00183.x","article-title":"The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety","volume":"76","author":"Przedborski","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2007.08.033_bib30","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0014-4886(02)00050-X","article-title":"Acute and subchronic MPTP administration differentially affects striatal glutamate synaptic function","volume":"180","author":"Robinson","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainres.2007.08.033_bib31","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1080\/08916930600739605","article-title":"The complement system in central nervous system diseases","volume":"39","author":"Rus","year":"2006","journal-title":"Autoimmunity"},{"key":"10.1016\/j.brainres.2007.08.033_bib32","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/0006-8993(94)01264-I","article-title":"Complement-mediated neurotoxicity is regulated by homologous restriction","volume":"671","author":"Shen","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2007.08.033_bib33","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0306-4522(96)00545-3","article-title":"In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining","volume":"77","author":"Tatton","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2007.08.033_bib34","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00001756-200102120-00022","article-title":"Complement anaphylatoxin C3a is selectively protective against NMDA-induced neuronal cell death","volume":"12","author":"Van","year":"2001","journal-title":"NeuroReport"},{"key":"10.1016\/j.brainres.2007.08.033_bib35","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1749-6632.2003.tb03138.x","article-title":"Activation of complement in the central nervous system: roles in neurodegeneration and neuroprotection","volume":"992","author":"Van Beek","year":"2003","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.brainres.2007.08.033_bib36","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1523\/JNEUROSCI.22-05-01763.2002","article-title":"Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease","volume":"22","author":"Wu","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2007.08.033_bib37","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/BF00427222","article-title":"Lewy bodies in Parkinson's disease are recognized by antibodies to complement proteins","volume":"84","author":"Yamada","year":"1992","journal-title":"Acta Neuropathol.(Berl.)"}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899307018823?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899307018823?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T17:35:58Z","timestamp":1757784958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899307018823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":37,"alternative-id":["S0006899307018823"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2007.08.033","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complement 3-deficient mice are not protected against MPTP-induced dopaminergic neurotoxicity","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2007.08.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}